We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-19.25%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$585M
AUM Growth
-$382M
Cap. Flow
-$229M
Cap. Flow %
-39.19%
Top 10 Hldgs %
61.33%
Holding
429
New
88
Increased
84
Reduced
102
Closed
122

Sector Composition

Rank Sector Weight
1 Energy 82.73%
2 Healthcare 7.29%
3 Utilities 2.06%
4 Financials 0.12%
5 Technology 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHLX
26
DELISTED
Shell Midstream Partners, L.P.
SHLX
$2.26M 0.39%
137,490
+1,014
+0.7% +$20K
NEE icon
27
NextEra Energy
NEE
$187B
$2.17M 0.37%
49,916
CEQP
28
DELISTED
Crestwood Equity Partners LP
CEQP
$2.01M 0.34%
72,150
-85,802
-54% -$2.81M
ENBL
29
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$1.28M 0.22%
94,921
-5,629
-6% -$83.1K
DTE icon
30
DTE Energy
DTE
$31.1B
$1.11M 0.19%
11,877
SRE icon
31
Sempra
SRE
$60.8B
$922K 0.16%
17,036
-952
-5% -$54.3K
PEG icon
32
Public Service Enterprise Group
PEG
$39.8B
$806K 0.14%
15,489
WEC icon
33
WEC Energy
WEC
$37.7B
$696K 0.12%
10,042
+451
+5% +$31.7K
NI icon
34
NiSource
NI
$22.4B
$692K 0.12%
27,295
CMS icon
35
CMS Energy
CMS
$23.1B
$646K 0.11%
13,021
+214
+2% +$10.8K
ES icon
36
Eversource Energy
ES
$28.2B
$645K 0.11%
9,921
RDUS
37
DELISTED
Radius Health, Inc.
RDUS
$643K 0.11%
39,000
+13,535
+53% +$228K
D icon
38
Dominion Energy
D
$62.5B
$642K 0.11%
8,990
+179
+2% +$13.1K
PTLA
39
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$636K 0.11%
32,607
+13,746
+73% +$283K
IONS icon
40
Ionis Pharmaceuticals
IONS
$9.35B
$615K 0.11%
11,369
-5,163
-31% -$263K
MDCO
41
DELISTED
Medicines Co
MDCO
$609K 0.1%
31,840
+10,505
+49% +$244K
LOXO
42
DELISTED
Loxo Oncology, Inc
LOXO
$605K 0.1%
4,322
+1,684
+64% +$256K
GILD icon
43
Gilead Sciences
GILD
$161B
$603K 0.1%
9,633
-1,852
-16% -$129K
UTHR icon
44
United Therapeutics
UTHR
$26.3B
$603K 0.1%
5,536
-1,320
-19% -$153K
ONCE
45
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$596K 0.1%
15,231
+5,069
+50% +$220K
REGN icon
46
Regeneron Pharmaceuticals
REGN
$68.8B
$594K 0.1%
1,591
-889
-36% -$325K
NBIX icon
47
Neurocrine Biosciences
NBIX
$17.7B
$592K 0.1%
8,285
+462
+6% +$44.3K
VNDA icon
48
Vanda Pharmaceuticals
VNDA
$312M
$592K 0.1%
22,661
-20,116
-47% -$473K
MNTA
49
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$588K 0.1%
53,282
+19,249
+57% +$268K
LGND icon
50
Ligand Pharmaceuticals
LGND
$6.02B
$586K 0.1%
6,928
+396
+6% +$42.2K

Similar funds

Virtus ETF Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, Virtus ETF Advisers held 429 positions worth $585M, down 40% from $968M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Virtus ETF Advisers withdrew a net $229M in Q4 2018, closing 122 positions and reducing 102 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $77.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 83% of assets, up from 68% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Virtus ETF Advisers opened a new position in Amyris Inc. worth $251K.

  • Virtus ETF Advisers's largest Q4 2018 buy was Amyris Inc.: 75,294 shares worth $251K.
  • Virtus ETF Advisers added most to Energy Transfer Partners in Q4 2018, an estimated $50.2M increase.
  • Virtus ETF Advisers's biggest Q4 2018 reduction was Marathon Petroleum, cutting an estimated $28.8M.
  • Virtus ETF Advisers fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $77.3M.
  • Virtus ETF Advisers's ten largest holdings make up 61% of its $585M portfolio in Q4 2018.
  • Virtus ETF Advisers opened 88 new positions and closed 122 in Q4 2018.
  • Virtus ETF Advisers's portfolio value fell 40% quarter-over-quarter to $585M.

Based on Virtus ETF Advisers's 13F filing for Q4 2018, filed 5 Feb 2019.